Circulating Tumor DNA Methylation Is a Biomarker of Poor Recurrence-free Survival in Locally-Advanced Rectal Cancer. Sugimoto K, Irie T, Momose H, Kochi S, et al. Anticancer Res 2025;45:1559-1573.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sugimoto K, Irie T, Momose H, Kochi S, et al. Circulating Tumor DNA Methylation Is a Biomarker of Poor Recurrence-free Survival in Locally-Advanced Rectal Cancer. Anticancer Res 2025;45:1559-1573.
PMID: 40155013